Den europeiske union - norsk - EMA (European Medicines Agency)

novartis europharm limited - sacubitril, valsartan - hjertefeil - angiotensin ii antagonister, andre kombinasjoner, agenter som handler på renin-angiotensin-systemet - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.

Den europeiske union - norsk - EMA (European Medicines Agency)

novartis europharm limited - sacubitril, valsartan - hjertefeil - agenter som virker på renin-angiotensinsystemet - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.

Norge - norsk - Statens legemiddelverk

2care4 - sakubitril / valsartan - tablett, filmdrasjert - 24 mg / 26 mg

Norge - norsk - Statens legemiddelverk

2care4 - sakubitril / valsartan - tablett, filmdrasjert - 49 mg / 51 mg

Norge - norsk - Statens legemiddelverk

2care4 - sakubitril / valsartan - tablett, filmdrasjert - 97 mg / 103 mg

Den europeiske union - norsk - EMA (European Medicines Agency)

bayer ag - vericiguat - hjertefeil - hjertetapi - treatment of symptomatic chronic heart failure.

Norge - norsk - Statens legemiddelverk

sanofi-aventis norge (3) - ramipril - tablett - 5 mg

Norge - norsk - Statens legemiddelverk

sanofi-aventis norge (3) - ramipril - tablett - 2.5 mg

Norge - norsk - Statens legemiddelverk

sanofi-aventis norge (3) - ramipril - tablett - 10 mg

Norge - norsk - Statens legemiddelverk

mylan ab - kaptopril - tablett - 12.5 mg